M channel enhancers and physiological M channel block

Journal of Physiology

Volumn 590, Issue 4, 2012, Pages 793-807

  Linley, John E ^a,b   Pettinger, Louisa ^a   Huang, Dongyang ^c   Gamper, Nikita ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALMODULIN; FLUPIRTINE; HYDROGEN PEROXIDE; M CHANNEL; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; POTASSIUM CHANNEL KCNQ5; PYRITHIONE ZINC; RETIGABINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; ENZYME MECHANISM; INFLAMMATION; NERVE CELL MEMBRANE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN DEPLETION; SENSORY NERVE CELL; SPINAL GANGLION;

AMINOPYRIDINES; ANIMALS; BRADYKININ; CALCIUM; CARBAMATES; CHO CELLS; CRICETINAE; CRICETULUS; GANGLIA, SPINAL; HYDROGEN PEROXIDE; INFLAMMATION; KCNQ POTASSIUM CHANNELS; ORGANOMETALLIC COMPOUNDS; PAIN; PHENYLENEDIAMINES; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PYRIDINES; RATS; RATS, WISTAR; SENSORY RECEPTOR CELLS; TYPE C PHOSPHOLIPASES;

EID: 84856920657     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.223404     Document Type: Article

References (44)

1. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ & Steinlein OK (1998). A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406.
2. Binshtok AM, Bean BP & Woolf CJ (2007). Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 449, 607-610.
3. Blackburn-Munro G & Jensen BS (2003). The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur J Pharmacol 460, 109-116.
4. Brown DA & Passmore GM (2010). Some new insights into the molecular mechanisms of pain perception. J Clin Invest 120, 1380-1383.
5. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ & Leppert M (1998). A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18, 53-55.
6. Crozier RA, Ajit SK, Kaftan EJ & Pausch MH (2007). MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J Neurosci 27, 4492-4496.
7. Delmas P & Brown DA (2005). Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 6, 850-862.
8. Delmas P, Coste B, Gamper N & Shapiro MS (2005). Phosphoinositide lipid second messengers: new paradigms for calcium channel modulation. Neuron 47, 179-182.
9. Emery EC, Young GT, Berrocoso EM, Chen L & McNaughton PA (2011). HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science 333, 1462-1466.
10. Etzioni A, Siloni S, Chikvashvilli D, Strulovich R, Sachyani D, Regev N, Greitzer-Antes D, Hirsch JA & Lotan I (2011). Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A. J Neurosci 31, 14158-14171.
11. 2+/calmodulin. Mol Biol Cell 16, 3538-3551.
12. + channels. J Gen Physiol 122, 17-31.
13. 2 signalling: how might it work? J Physiol 582, 967-975.
14. Gamper N, Stockand JD & Shapiro MS (2005b). The use of Chinese hamster ovary (CHO) cells in the study of ion channels. J Pharmacol Toxicol Methods 51, 177-185.
15. + channels as a mechanism of cytoprotective neuronal silencing. EMBO J 25, 4996-5004.
16. Gribkoff VK (2003). The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin Ther Targets 7, 737-748.
17. Gribkoff VK (2008). The therapeutic potential of neuronal Kv7 (KCNQ) channel modulators: an update. Expert Opin Ther Targets 12, 565-581.
18. Hernandez CC, Zaika O, Tolstykh GP & Shapiro MS (2008). Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J Physiol 586, 1811-1821.
19. Kubisch C, Schroeder BC, Friedrich T, Lutjohann B, El-Amraoui A, Marlin S, Petit C & Jentsch TJ (1999). KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 437-446.
20. + channel open probability by phosphatidylinositol (4, 5)-bisphosphate. J Neurosci 25, 9825-9835.
21. Linley JE, Rose K, Ooi L & Gamper N (2010). Understanding inflammatory pain: ion channels contributing to acute and chronic nociception. Pflugers Arch 459, 657-669.
22. Linley JE, Rose K, Patil M, Robertson B, Akopian AN & Gamper N (2008). Inhibition of M current in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception. J Neurosci 28, 11240-11249.
23. - channels. J Clin Invest 120, 1240-1252.
24. Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ & Burbidge SA (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 58, 253-262.
25. Mucha M, Ooi L, Linley JE, Mordaka P, Dalle C, Robertson B, Gamper N & Wood IC (2010). Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J Neurosci 30, 13235-13245.
26. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwartz K & Guicheney P (1997). A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15, 186-189.
27. Passmore GM, Selyanko AA, Mistry M, Al-Qatari M, Marsh SJ, Matthews EA, Dickenson AH, Brown TA, Burbidge SA, Main M & Brown DA (2003). KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci 23, 7227-7236.
28. Rose K, Ooi L, Dalle C, Robertson B, Wood IC & Gamper N (2011). Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain 152, 742-754.
29. + channel sensitivity to the anticonvulsant retigabine. J Neurosci 25, 5051-5060.
30. Selyanko AA & Brown DA (1996). Intracellular calcium directly inhibits potassium M channels in excised membrane patches from rat sympathetic neurons. Neuron 16, 151-162.
31. Shapiro MS, Gamper N (2009). Regulation of neuronal ion channels by G-protein-coupled receptors in sympathetic neurons. In Structure, Function and Modulation of Neuronal Voltage-Gated Ion Channels, ed. Gribkoff VK & Kaczmarek LK, pp. 291-316. Wiley, Hoboken, NJ, USA
32. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV, McHarg ML, Gagnon D, Rosales TO, Peiffer A, Anderson VE & Leppert M (1998). A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18, 25-29.
33. Ks function. Nat Genet 17, 338-340.
34. Suh B & Hille B (2002). Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4, 5-bisphosphate synthesis. Neuron 35, 507-520.
35. 2 gate KCNQ ion channels. Science 314, 1454-1457.
36. Tatulian L & Brown DA (2003). Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J Physiol 549, 57-63.
37. Tatulian L, Delmas P, Abogadie FC & Brown DA (2001). Activation of expressed KCNQ potassium currents and native neuronal M- type potassium currents by the anti-convulsant drug retigabine. J Neurosci 21, 5535-5545.
38. Varnai P, Thyagarajan B, Rohacs T & Balla T (2006). Rapidly inducible changes in phosphatidylinositol 4, 5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells. J Cell Biol 175, 377-382.
39. Wen H & Levitan IB (2002). Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels. J Neurosci 22, 7991-8001.
40. Wickenden AD, Yu W, Zou A, Jegla T & Wagoner PK (2000). Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 58, 591-600.
41. Wuttke TV, Seebohm G, Bail S, Maljevic S & Lerche H (2005). The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 67, 1009-1017.
42. Xiong Q, Sun H & Li M (2007). Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants. Nat Chem Biol 3, 287-296.
43. Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY & Blanar MA (1997). KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A 94, 4017-4021.
44. 2 activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37, 963-975.